Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantQuality of LifeCombined Modality TherapyAntineoplastic AgentsTumor Markers, BiologicalTreatment OutcomeCisplatinDoxorubicinCell Line, TumorCyclophosphamideTumor BurdenNeoplasm StagingTumor Necrosis Factor-alphaBreast NeoplasmsDisease-Free SurvivalSurvival AnalysisNeoadjuvant TherapySurvival RateBrain NeoplasmsWilms TumorNeoplasm MetastasisPrognosisNeoplasmsEtoposideAdenocarcinomaLung NeoplasmsNeoplasm Recurrence, LocalNeoplasms, ExperimentalTumor Suppressor Protein p53Drug Administration ScheduleOvarian NeoplasmsTime FactorsGenes, Tumor SuppressorPaclitaxelCarcinoid TumorMethotrexateCarboplatinLiver NeoplasmsFollow-Up StudiesNeuroendocrine TumorsTumor Suppressor ProteinsVinblastineTesticular NeoplasmsTumor MicroenvironmentBone NeoplasmsInduction ChemotherapyAntimetabolites, AntineoplasticNeovascularization, PathologicCarcinoma, Squamous CellXenograft Model Antitumor AssaysCarcinoma, Non-Small-Cell LungDisease ProgressionIfosfamideColonic NeoplasmsMammary Neoplasms, ExperimentalDeoxycytidineAntineoplastic Agents, AlkylatingBleomycinTaxoidsAntibodies, MonoclonalCell ProliferationNeoplasms, Germ Cell and EmbryonalOrganoplatinum CompoundsTransplantation, HeterologousLymphatic MetastasisLifeDose-Response Relationship, DrugPancreatic NeoplasmsDrug Resistance, NeoplasmProspective StudiesOsteosarcomaNeoplasm ProteinsChemotherapy, Cancer, Regional PerfusionMice, Inbred BALB CStomach NeoplasmsGliomaAntibiotics, AntineoplasticKaplan-Meier EstimateAntigens, NeoplasmAnthracyclinesRadiotherapySalvage TherapyImmunohistochemistryLymphomaRadiotherapy, AdjuvantLymphoma, Non-HodgkinCytarabineGastrointestinal Stromal TumorsMice, NudeKidney NeoplasmsRNA, MessengerTomography, X-Ray ComputedCell DivisionSarcomaSkin NeoplasmsHead and Neck NeoplasmsDacarbazinePeritoneal NeoplasmsHodgkin Disease